Novartis has announced today the launch of a new high quality antimalarial formulation of Coartem® 80/480 (artemether/lumefantrine 80 mg/480 mg), for the treatment of uncomplicated malaria in adults and older children who weigh above 35kg.
The drug has been registered by the Pharmacy and poisons board in Kenya and has already been launched in Nigeria and Angola. Kenya is the 3rd country in Africa to launch Coartem 80/480. Other countries that have registered Coartem 80/480 include Uganda and Ghana.




